loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 202091 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 LUPIN LTD (1)

filter

01 FOR SUSPENSION;ORAL (1)

filter

01 RX (1)

filter

01 SUPRAX (1)

filter

01 Yes (1)

URL Supplier Web Content
FOR SUSPENSION; OR...
500MG/5ML
2013-02-20
202091
SUPRAX
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 202091

Looking for FDA Orange Book APPLICATION 202091 1

19

Lupin Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is CEFIXIME, with a corresponding application number 202091.

Regulatory Information RX

With a dosage strength 500MG/5ML

Dosage Form Route FOR SUSPENSION; ORAL

Reference Listed Drug Yes

Approved since 2013-02-20

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY